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Abstract
 
Dendritic cells (DCs) activated by CD40L-expressing CD4
 
 
 
 T cells act as mediators of “T
helper (Th)” signals for CD8
 
 
 
 T lymphocytes, inducing their cytotoxic function and support-
ing their long-term activity. Here, we show that the optimal activation of DCs, their ability to
produce high levels of bioactive interleukin (IL)-12p70 and to induce Th1-type CD4
 
 
 
 T cells,
is supported by the complementary DC-activating signals from both CD4
 
 
 
 and CD8
 
 
 
 T cells.
Cord blood– or peripheral blood–isolated naive CD8
 
 
 
 T cells do not express CD40L, but, in
contrast to naive CD4
 
 
 
 T cells, they are efficient producers of IFN-
 
 
 
 at the earliest stages of
the interaction with DCs. Naive CD8
 
 
 
 T cells cooperate with CD40L-expressing naive CD4
 
 
 
T cells in the induction of IL-12p70 in DCs, promoting the development of primary Th1-type
CD4
 
 
 
 T cell responses. Moreover, the recognition of major histocompatibility complex class
I–presented epitopes by antigen-specific CD8
 
 
 
 T cells results in the TNF-
 
 
 
– and IFN-
 
 
 
–depen-
dent increase in the activation level of DCs and in the induction of type-1 polarized mature
DCs capable of producing high levels of IL-12p70 upon a subsequent CD40 ligation. The ability
of class I–restricted CD8
 
 
 
 T cells to coactivate and polarize DCs may support the induction of
Th1-type responses against class I–presented epitopes of intracellular pathogens and contact
allergens, and may have therapeutical implications in cancer and chronic infections.
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Introduction
 
Effective cell-mediated immunity, essential for the protec-
tion against chronic intracellular infections and cancer, de-
pends on the concordant activity of CD8
 
 
 
 T cells (CTL)
and CD4
 
 
 
 T cells, especially Th1 cells (1). Dendritic cells
(DCs),
 
*
 
 the carriers of pathogen-related information within
the immune system (2), are essential for the interaction be-
tween the above T cell subsets. The ability of DCs to
“translate” the CD40L-dependent helper signal from CD4
 
 
 
T cells into an enhanced ability to induce and support effec-
tor functions of CD8
 
 
 
 T cells (3–5), allows them to act as a
“spatial and temporal bridge” linking the responses of
“helper” CD4
 
 
 
 and “effector” CD8
 
 
 
 T cells (3). In contrast
to the well established role of DCs in mediating such CD4
to CD8 helper signals, it remains unclear whether they also
mediate “reverse” CD8
 
 
 
 to CD4
 
 
 
 T cell communication.
CD8
 
 
 
 T cells, recognizing MHC class I–restricted viral
epitopes, can be effectively triggered by virus-infected cells
(3) and are capable of activating the Ag-carrying DCs and
bystander DCs in a CD40L and TNF-related activation-
induced cytokine (TRANCE)/receptor activator of nu-
clear factor 
 
 
 
B (RANK)-independent mechanism (6, 7).
However, it remains unknown whether the DC–CD8
 
 
 
 T
cell interaction results in any DC-carried signals that affect
the character of CD4
 
 
 
 T cell responses.
Here, we show that in a sharp contrast to naive CD4
 
 
 
 T
cells, naive CD8
 
 
 
 T cells are capable of IFN-
 
 
 
 and TNF-
 
 
 
production at early time-points of their priming, and effi-
ciently synergize with CD40L-expressing naive Th cells in
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the optimal activation of DCs and the induction of IL-12
p70, the factor playing a key role in the CTL-, Th1-, and
NK cell–dependent cell-mediated immunity (8). This
novel “helper” function of CD8
 
 
 
 T cells in the DC-medi-
ated polarization CD4
 
 
 
 T cell responses may provide a re-
liable mechanism of inducing the desirable Th1-type re-
sponses against intracellular pathogens. This additional
Th1-inducing pathway is not contingent on the pathogen’s
intrinsic ability to induce IL-12 (9, 10) or IFN-
 
 
 
 (11, 12),
but utilizes the ability of CD8
 
 
 
 T cells to detect MHC
class I–presented foreign epitopes as a cue for the patho-
gen’s intracellular character.
 
Materials and Methods
 
Media, Reagents, and Transformed Cell Lines.
 
All cultures were
performed in IMDM (Life Technologies) with gentamycin (250
ng/ml; Life Technologies) supplemented with 10% FCS (Hy-
clone). RhuGM-CSF and IL-4 were gifts from Schering-Plough.
Human recombinant IL-2 was a gift from the Chiron Corpora-
tion (Emeryville, CA). 
 
rh
 
TNF and 
 
rh
 
IFN-
 
 
 
 were purchased from
Strathman Biotech. LPS and Staphylococcus Enterotoxin B
(SEB) were purchased from Sigma-Aldrich. CD3 mAb (OKT3),
used as a surrogate Ag, was purchased from Ortho-Biotech. CD3
(CLB-T3/4.E) and CD28 (CLB-CD28/1) mAbs (both from
CLB) were used to induce cytokine production in T cells.
CD40L-transfected J558 plasmacytoma cells (J558-CD40L; refer-
ence 13), were a gift of Dr. P. Lane, University of Birmingham,
Birmingham, UK. The HLA-DR4–transfected, HLA-class I A2
expressing T2 cell line was provided by Dr. J. Blum, University
of Indiana, Indianapolis, IN.
 
Isolation of Peripheral Blood and Cord Blood T Cell Populations.
 
Mononuclear cells, obtained from peripheral blood of healthy
donors or from cord blood, were isolated by LymphoPrep™
(Nycomed Pharma). Naive CD4
 
 
 
CD45RA
 
 
 
 T cells, and naive
and bulk populations of CD8
 
  
 
T cells were isolated by negative
selection with StemSep™ (StemCell Technologies Inc.). CD8
 
 
 
T cells were selected using the StemSep™ CD8 T cell enrich-
ment cocktail. The selected population contained both memory
(CD45RO
 
 
 
) and naive (CD45RA
 
 
 
) CD8
 
 
 
 T cells and are re-
ferred to as “bulk” CD8
 
 
 
 T cells. Isolation of naive CD4
 
 
 
 T cells
and naive CD8
 
 
 
 was performed by the pretreatment of PBMCs
or cord-blood-isolated mononuclear cells with biotin-labeled
anti-CD45RO mAb, followed by the incubation with custom-
ized StemSep™ naive CD4 and CD8 T cell selection cocktails
containing anti-biotin mAb tetramer. Percentage of double-posi-
tive CD45RA
 
 
 
/CD4
 
 
 
 and CD45RA
 
 
 
/CD8
 
 
 
 cells in the iso-
lated populations ranged between 95–98%, as determined by
FACS
 
®
 
. Contamination with memory CD45RO
 
 
 
 T cells in ei-
ther of the isolated naive T cell populations was below 1% (see
Fig. 1).
 
Class I–restricted Melanoma-specific and Influenza-specific CD8
Cells.
 
The HLA-A2–restricted CD8
 
 
 
 CTL clone, recognizing
melanoma antigen gp100 (209–217, ITDQVPFSV), was cloned
from the TIL1520 cell line (14) provided by Drs. Steven Rosen-
berg and John Wunderlich (National Cancer Institute, Bethesda,
MD). Influenza-specific CD8
 
 
 
 T cells, recognizing the influenza
peptide (Flu M1; 58–66; GILGFVFTL) in context of HLA-A2.1,
were obtained from the CD8
 
 
 
 T cell fraction of fresh blood by
specific tetramer isolation (15). After isolation, the cells were cul-
tured for 2 wk in the presence of IL-2 and IL-7 and stimulated
with peptide-loaded autologous DCs, 10 d before use. The fre-
quency of tetramer-binding cells was 
 
 
 
50% (see Fig. 4 A).
 
Generation of DCs.
 
To obtain immature “day 6 DCs”, pe-
ripheral blood monocytes (5 
 
  
 
10
 
5
 
 cells/well) were cultured in
FCS/IMDM with GM-CSF and IL-4 (both 1,000 U/ml) in 24-
well plates (Costar), as described (16). At day 6, the cultures con-
sisted uniformly of CD1a
 
 
 
CD14
 
 
 
, HLA-DR
 
 
 
, negative for
CD83, the human DC maturation marker, and expressed inter-
mediate levels of such costimulatory molecules as CD54 and
CD86 (see Fig. 3). The number of such “day 6 DCs” varied be-
tween 2–4 
 
  
 
10
 
5
 
 cells/well, depending on the donor. In the ini-
tial set of experiments (Figs. 1 and 2 only), in addition to such
“day 6 DC,” we also used the DCs that were stimulated over-
night with TNF-
 
 
 
 (50 ng/ml; Strathmann) to enhance their ex-
pression of costimulatory factors and their T cell stimulatory ac-
tivity. Such cells are referred to as “TNF-
 
 
 
–preactivated DCs.”
In the following experiments (DC activation and polarization),
we used immature “day 6 DCs.”
 
Induction of IFN-
 
 
 
 and IL-12p70 in Triple Cultures of DCs,
CD4
 
 
 
, and CD8
 
 
 
 T Cells.
 
Day 6 DCs were stimulated over-
night with TNF-
 
 
 
 (50 ng/ml; Strathmann), pulsed with SEB (1
ng/ml) for 30 min, subsequently washed, and plated (2 
 
 
 
 10
 
4
 
cells/well) in 96-well flat-bottom culture plates (Costar). Naive
CD45RA
 
 
 
CD4
 
 
 
 T cells (10
 
5
 
 cells/well) were added, either in
the absence or in the presence of naive CD45RA
 
 
 
CD8
 
 
 
 T cells
or bulk CD8
 
 
 
 T cells (10
 
5
 
 cells/well in either case), up to a total
volume of 200 
 
 
 
l. Cytokine-containing supernatants were col-
lected after 48 h.
 
Differential Priming of Naive Th Cells.
 
The priming cultures
consisted of SEB-pulsed DCs (2 
 
 
 
 10
 
4
 
 cells/well) and
CD45RA
 
 
 
CD4
 
 
 
 Th cells (10
 
5
 
 cells/well) with or without
 
 
 
-irradiated (3,000 Rad) CD45RA
 
 
 
CD8
 
 
 
 T cells (10
 
5
 
 cells/
well). On day 3, rhIL-2 (50 IU/ml) was added to the cultures. At
day 10–12, the expanded CD4
 
 
 
 cells (100–300-fold expansion of
CD4
 
 
 
 cells, death of irradiated CD8
 
 
 
 cells) were washed,
counted, plated in 96-well plates (10
 
5
 
 cells/well) and stimulated
with CD3 (1 
 
 
 
g/ml) and CD28 (2 
 
 
 
g/ml) mAb. The superna-
tants were collected after 24 h and analyzed for the presence of
IL-4 and IFN-
 
 
 
.
 
Direct Cocultures of DCs with CD8
 
 
 
 Cells and Transwell Experi-
ments.
 
Freshly isolated bulk or naive CD8
 
 
 
 T cells, gp100-spe-
cific clone, or influenza-specific CD8
 
 
 
 T cells (2 
 
 
 
 10
 
5
 
 cells in
each case) were added to day 6 DC cultures, either in the absence
or in the presence of the relevant Ag (gp100 [209–217] peptide,
or influenza [Flu M1; 58–66] peptide) or antigen surrogates (SEB
[1 ng/ml], or OKT3 mAb [1 
 
 
 
g], as indicated). After 48 h incu-
bation, the cells were harvested, washed, and either analyzed by
FACS
 
®
 
, or counted and stimulated (2 
 
 
 
 10
 
4
 
 cells in 0.2 ml) in 96
wells with CD40L-transfected J558 cells (5 
 
 
 
 10
 
4
 
 cells) for 24 h.
When indicated, instead of adding CD8
 
 
 
 T cells directly to DC
cultures, 2 
 
 
 
 10
 
5
 
 CD8
 
 
 
 T cells and 3 
 
 
 
 10
 
4
 
 APCs (autologous
DCs or HLA-A2
 
 
 
DR4
 
 
 
 T2 cells) were placed in the upper
chamber of Transwell™ culture inserts (Costar-3413; pore size of
0.4 
 
 
 
m), in the absence or the presence of relevant antigens. Af-
ter 48 h, DCs from the lower chamber were harvested, washed,
and analyzed as described above. To neutralize the biological ac-
tivity
 
 
 
of TNF-
 
 
 
 and IFN-
 
 
 
 in CD8
 
 
 
 T cell–DC cocultures, hu-
man soluble TNF receptor I (sTNF RI; 1 
 
 
 
g/ml; R&D Systems)
or IFN-
 
 
 
 receptor 1 (IFN-
 
 
 
 R1; 10 
 
 
 
g/ml; R&D Systems) were
added at the beginning of cocultures.
 
Flow Cytometry.
 
Cell surface phenotypes were analyzed by
FACScan™ (Becton Dickinson). The FITC- and PE-labeled
isotype control (mouse IgG1 and IgG2a), anti–human CD86, 
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CD54, CD3, CD4, CD8, HLA-DR, CD45RA, CD45RO, and
CD14 mAbs were purchased from BD PharMingen. CD83 mAb
was obtained from Immunotech. CD1a mAb was purchased
from Diaclone.
 
Cytokine Detection.
 
Concentrations of IL-12p70, TNF-
 
 
 
,
IFN-
 
 
 
, and IL-4, were determined by specific ELISAs, per-
formed with the matched reagents from Endogen.
 
Results
 
Naive CD8
 
 
 
 T Cells Cooperate with Naive CD4
 
 
 
 T Cells
in the Induction of IL-12 in DCs and Promote the Development
of Primary Th1 Responses.
 
An efficient induction of bioac-
tive IL-12p70 during the interaction of CD4
 
 
 
 T cells with
DCs depends on CD40–CD40L interaction, but requires
a costimulatory signal which can be provided by such
endogenous factors as IFN-
 
 
 
 (17, 18) or IL-4 (19,
20), or by pathogen-related signals (8–12, 16–20). Naive
CD45RA
 
 
 
CD4
 
 
 
 T cells are poor producers of either fac-
tor within the first days of their priming (21–23), which al-
lows for only limited induction of IL-12 during their inter-
action with DCs (17, 18). While memory/effector CD4
 
 
 
T cells are known to produce substantial amounts of IFN-
 
 
 
and IL-4 and effectively induce IL-12, the mechanism of
endogenous IL-12 induction during primary Th1 responses
remains elusive.
Unexpectedly, in sharp contrast to naive CD4
 
 
 
CD45R0
 
 
 
/RA
 
 
 
 cells (Fig. 1 A), that did not produce
detectable amounts of IFN-
 
 
 
 at the early time points of
their priming (Fig. 1 B), and acquired the ability to pro-
duce this factor with a 72 h delay (data not shown), naive
CD8
 
 
 
CD45R0
 
 
 
/RA
 
 
 
 proved to be highly efficient pro-
ducers of IFN-
 
 
 
, already within 24 h of their priming (Fig.
1 B). High IFN-
 
 
 
–producing ability was similarly well-
pronounced in CD8
 
 
 
CD45R0
 
 
 
/RA
 
 
 
 isolated from cord
blood and from peripheral blood and was both observed af-
ter the stimulation with a pair of CD3 and CD28 stimula-
tory mAbs, or during the interaction with DC in a super-
antigen (SEB) model, that allows stimulation of a high
proportion of both CD4
 
 
 
 and CD8
 
 
 
 T cells expressing the
appropriate TCR V
 
 
 
 chains (24; Fig. 1 B). Although the
ability to induce IFN-
 
 
 
 production in naive CD8
 
 
 
 T cells
was especially well pronounced in the case of TNF-
 
 
 
–pre-
treated DCs (Fig. 1 B), similar differences in the IFN-
 
 
 
production were also observed when we used TNF-
 
 
 
–
untreated, CD83
 
 
 
, day 6 monocyte-derived DCs (data not
shown), consistent with their expression of significant
amounts of costimulatory molecules already at that stage
(reference 25, also see the current data below). CD40L ex-
pression by the two populations showed a pattern recipro-
cal to their IFN-
 
 
 
–producing abilities, being restricted to
activated naive CD4
 
 
 
 T cells and absent in CD8
 
 
 
 T cells
(Fig. 1 C).
In accordance with the two-signal requirement for the
induction of IL-12p70 in DCs (10, 17, 18) 48 h cocultures
of SEB-presenting DCs with CD45RA
 
 
 
 CD4
 
 
 
 naive Th
cells did not yield any detectable IL-12p70 production
(Fig. 2 A), consistent with the ability of naive Th cells to
provide a CD40L-mediated stimulus, but not the IFN-
 
 
 
–
mediated IL-12–coinducing signal (17, 18). The parallel
cultures of naive CD45RA
 
 
 
CD8
 
 
 
 T cells with DCs
yielded high concentrations of IFN-
 
 
 
, comparable to these
found in the cocultures of DCs with bulk CD8
 
 
 
 T cells,
but neither naive nor memory CD8
 
 
 
 T cells were able to
induce IL-12p70 by themselves, a finding consistent with
the absence of CD40L on their surface (Fig. 1 C) and the
Figure 1. Cord blood– and peripheral blood–isolated CD45R0 /RA 
CD4  and CD8  T cells show a mutually exclusive expression of CD40L
and IFN- . (A) Expression of CD45RA and CD45RO on peripheral
blood-isolated naive CD4  and CD8  T cells. Similar data were obtained
using cord blood–isolated cells. (B) Differential ability of naive CD4 
and CD8  T cell populations to produce IFN- . Freshly-isolated
CD45R0 /RA  CD4  and CD8  T cells (105 cells/well) from periph-
eral blood (white bars) or from cord blood (black bars) were stimulated
for 24 h with the stimulatory combination of CD3 and CD28 mAbs (top)
or with 2   104 TNF- –preactivated SEB-coated DCs (bottom). Con-
centrations of IFN-  in 24 h supernatants were analyzed with specific
ELISA. The data (mean   SD) represent one experiment of three (cord
blood) or five (peripheral blood) that all yielded similar results. (C) The
presence of CD40L on activated T cell populations from cord blood was
analyzed in T cell cultures stimulated with CD3 and CD28 mAbs for 24 h.
Similar data was obtained in case of peripheral blood–isolated T cells.476 Modulation of DC Functions by CD8  T Cells
inability of CD8  T cells to provide DCs with the CD40-
mediated activating signal (3–5). In sharp contrast, the si-
multaneous interaction of DCs with both naive CD8  and
naive CD4  Th cells resulted in the effective induction of
IL-12p70 production (Fig. 2 A).
To test the modulatory impact of CD8  T cells on the
development of naive Th cells into Th1- or Th2-type
effector/memory cells, we compared the outcome of prim-
ing of CD45RA  CD4  T cells by SEB-primed DCs ei-
ther in the absence or in the presence of 3,000 Rad-
irradiated CD45RA CD8  T cells. After 10 d of growth
(100- to 300-fold expansion of CD4  cells and death of ir-
radiated CD8  cells), such differentially primed Th cells
were restimulated with CD3 and CD28 mAb to analyze
their cytokine production profiles. As shown in Fig. 2 B,
CD4  Th cells primed in the presence of naive CD8  T
cells developed strongly polarized Th1-type cytokine pro-
file, characterized by the production of high amounts of
IFN- , but only trace quantities of IL-4. In contrast, the
priming cultures performed in the absence of irradiated
CD8  T cells yielded the memory/effector Th cells with
strongly reduced IFN-  and enhanced IL-4 production.
Thus, the unique ability of naive CD8  T cells to produce
IFN- , a necessary cofactor of CD40L-induced IL-12 pro-
duction in DCs (18), allows them to play a “helper” role
during the induction of primary Th1-type responses.
Class I-restricted CD8  T Cells Enhance the Activation Stage
of Ag-bearing DCs. To test if the CD8  T cell–dependent
“help” in the development of polarized Th1 responses is
indeed mediated by the modulation of DC functions, we
analyzed the impact of CD8  T cells on DC activation/
maturation stage and the ability of DCs to produce IL-12.
Day 6 monocyte-derived DCs expressed intermediate lev-
els of costimulatory molecules, and lacked the expression of
CD83, human DC maturation marker (Fig. 3). DCs ex-
posed to CD8  T cell clone recognizing the 209–217
epitope (ITDQVPFSV) of the gp100 melanoma-associated
antigen in context of HLA-A2 (14) increased their surface
Figure 2. Complementary DC-activating signals from naive CD4  and
CD8  T cells result in the primary induction of IL-12 and the resulting
development of Th1 responses (A). TNF- –preactivated, SEB-coated
DCs (2   104 cells/well) were coincubated with naive CD45RA CD4 T
cells, naive CD8 , or bulk CD8  T cells (105 cells/well), or their combi-
nation. Concentrations of IL-12 in 48 h supernatants were analyzed with a
p70-specific ELISA. The data (mean   SD) represents one experiment of
four that yielded similar results. Similar results were obtained with day 6
DCs that had not been pretreated with TNF- . (B) CD45RA CD4  naive
Th cells (105 cells/well) were primed with TNF- –preactivated, SEB-
coated DCs (2   104 cells/well), either in the absence or in the presence
of  -irradiated CD45RA CD8  T cells (105 cells/well). At day 10, the
cultures contained a uniform population of CD4  Th (average of 100–
300-fold expansion) without any detectable surviving CD8  T cells ( 1%,
as determined by FACScan®). The cells were harvested, washed, and stim-
ulated for 24 h with CD3 and CD28 mAbs.
Figure 3. Class I–restricted melanoma (gp100)-specific CD8  T cell
clone induces DC activation. Day 6, immature HLA-A2  DCs (see Ma-
terials and Methods) were cocultured with melanoma gp100-specific
HLA-A2–restricted CD8  T cells (2   105 cells/well), in the presence of
the relevant gp100 (209–217) peptide (shaded histograms). The cells were
harvested 48 h later and analyzed by FACScan® for the level of expression
of costimulatory molecules, CD86 (B7.2) and CD54 (ICAM-1), and the
maturation-associated marker CD83. Cultures containing DCs alone or
DCs cultured with the CD8  T cell clone in the presence of an irrelevant
peptide, tyrosinase (368–376), were used as controls, as indicated. The
data shown is from a representative experiment of five performed. *Simi-
lar expression of the maturation-associated markers was found on DCs ex-
posed to Ag alone or to CD8  T cells alone, in this and all other experi-
ments. These additional negative controls are not shown for the sake of
clarity of the figures.477 Mailliard et al.
expression of costimulatory molecules and acquired CD83
expression (Fig. 3). These effects required both the relevant
class I–restricted antigenic peptide and the Ag-specific
CD8  T cells, indicating the specificity of the effect. A
similar maturation-inducing activity was also observed using
short-term cultured influenza-specific HLA-A2–restricted
CD8  T cells isolated from peripheral blood, using a spe-
cific tetramer (15) isolation (Fig. 4 A, see the inset for the
frequency of the tetramer positive T cells).
To test the DC-activating properties of resting memory
and naive CD8  T cells, we used the SEB model and a
CD3 mAb model, where low concentrations of OKT3
(IgG2a) mAb are captured by FcR on immature DCs and
“presented” to T cells (26). Freshly isolated human periph-
eral blood CD8  T cells induced the activation of DCs
in each of these models (Fig. 4 B). Similar to the class
I–restricted peptide models, this effect was also critically
dependent on the presence of CD8  T cells and an antigen
surrogate. SEB or soluble CD3 mAb were completely inef-
fective in the absence of CD8  T cells, demonstrating that
the observed DC activation was not caused by any contam-
inating CD40L-expressing CD4  T cells in DC prepara-
tion ( 1%) or by a direct action of these factors on DCs.
Experiments performed in a transwell system allowed us to
determine that the DC maturation-inducing activity of
CD8  T cells is mediated by soluble factor(s). Maturation
of DCs cultured in the bottom chamber critically depended
on the ability of CD8  T cells from the upper chamber to
recognize class I–restricted peptide or SEB presented on
the surface of DCs (Fig. 4 C).
The ability of both bulk CD8  T cells (Fig. 4 B) and na-
ive CD8  T cells isolated from cord blood (Fig. 4 D) or
peripheral blood (data not shown) to contribute to the
maturation of monocyte-derived DCs implicates that
CD8  T cells may affect DC activation status already dur-
ing primary immune responses. Importantly, however, the
release of the activating factor by resting naive CD8  T
cells required their activation by DCs, and could not be in-
duced by nonprofessional APCs, such as the HLA-A2 ,
DR4-transfected T2 cells (Fig. 5 A). In contrast, effector-
type CD8  T cells, such as gp100-specific CTLs, induced
DC maturation when stimulated either by peptide-present-
ing HLA-A2  autologous DCs (Figs. 3 and 4 C) or by pep-
tide-loaded T2 cells (Fig. 5 A). ELISA analysis revealed the
presence of TNF- , a known inducer of DC maturation,
in the supernatants from 48 h cocultures of DCs with
freshly isolated naive and bulk CD8  T cells, and with ef-
fector-type CD8  T cells (Fig. 5 B). TNF-  release was
observed in the cocultures of resting CD8  T cells with
DCs, but not with T2 cells, while in the case of effector
CD8  cells (gp100-specific CTLs) it could be induced both
by DCs and by the nonprofessional APCs (Fig. 5 B), a pat-
tern similar to the release of the DC maturation–inducing
activity. Indeed, TNF-  proved to be a critical factor for
the CD8  T cell induced DC maturation, as its neutraliza-
tion with soluble TNF receptor I (sTNF-RI) prevented the
CD8  T cell–induced DC maturation, both in direct cocul-
tures (Fig. 5 C) and in transwell experiments (Fig. 5 D).
Class I–restricted CD8  T Cells Induce Type-1 Polarized Ef-
fector DCs with Elevated IL-12–producing Capacity. In addi-
tion to the induction of DC maturation, the recognition of
MHC class I–presented Ag by CD8  T cells also results in
type-1 polarization of maturing DCs, manifested by their
enhanced ability to produce IL-12p70 after subsequent DC
stimulation. DCs cocultured for 48 h with gp100-specific
CTLs in the presence of gp100 peptide, then harvested,
washed, and stimulated with CD40L-transfected J558 cells
(J558-CD40L) produced strongly increased amounts of IL-
12p70 (Fig. 6 A). Similar effects were found in DCs cocul-
tured with influenza-specific tetramer-isolated CD8  T
cells and the relevant influenza-derived peptide (Fig. 6 A),
as well as in the cultures of DCs with freshly isolated CD8 
T cells in the presence of SEB (Fig. 6 B) or CD3 mAb (data
not shown). In all four systems, DC polarization required
the presence of both CD8  T cells and class I–restricted
antigenic peptides (or SEB/CD3 as Ag surrogates), con-
Figure 4. Short term-cultured class I–restricted influ-
enza-specific CD8  Th cells and freshly isolated naive
CD8  T cells enhance the activation status of DCs. (A)
Short term cultured tetramer-isolated influenza-specific
CD8  T cells (2   105 cells/well; see the inset for the fre-
quency of tetramer-binding cells) were cocultured with
HLA-A2  day 6 immature DCs in the presence of the rel-
evant influenza peptide or irrelevant peptide (tyrosinase).
(B) Day 6 DCs were cultured in the presence of SEB or
OKT3 (CD3) mAb, in the absence or in the presence of
bulk CD8  T cells (2   105 cells/well) freshly isolated
from peripheral blood. (C) Bystander activation of DCs by
freshly isolated naive CD8  T cells and gp100-specific
CTL clone in the transwell system. CD8  T cells (2   105
cells/well) and day 6 DCs (3   104 cells/well) were placed
in the upper chamber in the presence of absence of Ag
(SEB or gp100 peptide). Bottom chamber contained the
DCs serving as a readout of bystander activation. (D) DC-
activating properties of freshly isolated naive CD45RA/
CD8  T cells (2   105 cells/well) in the SEB model. 48 h
direct cocultures.478 Modulation of DC Functions by CD8  T Cells
firming the specificity of the effect. Interestingly, both bulk
and naive CD8  T cells displayed the ability to induce
type-1–polarized DCs (Fig. 6 B).
To test if the type-1–polarizing effect of CD8  T cells
required a direct cell-to-cell contact, we analyzed the abil-
ity of the HLA-A2–restricted, gp100-specific CTL clone,
and freshly isolated CD8  T cells to induce DC polariza-
tion in the transwell system. Similar to their ability to in-
duce DC maturation, Ag-driven interaction of the effec-
tor-type CD8  T cells with peptide-loaded T2 cells or
DCs in the upper chamber resulted in the polarization of
DCs in the bottom chamber, as evidenced by their
strongly elevated production of IL-12 after the subsequent
stimulation by J558-CD40L (Fig. 6 C). As in this model
CD8  T cells were no longer present during the CD40L-
mediated DC stimulation, these experiments eliminated
the possibility that the enhanced IL-12 production by
CD8  T cell–activated DCs resulted from the persistent
production of IFN-  by contaminating CD8  T cells. Al-
though resting CD8  T cells were effective inducers of
DC polarization upon a direct contact (Fig. 6 B) and could
also polarize bystander DCs in a transwell model (Fig. 6
C), their ability to release the polarizing activity strictly
depended on being activated by DCs, while T2 cells were
completely ineffective.
The CD8  T cell–dependent type-1 DC polarization
was strongly inhibited by the addition of either sTNF-RI
or soluble IFN-  receptor (sIFN- -R), indicating the re-
quirement for both of these CD8  T cell–derived factors
in DC polarization (Fig. 6 D). The effects of both agents
were especially pronounced in the transwell system, but
were also observed in the system of a direct DC–CD8  T
cell contact. The ability of neutralizing agents for either
TNF-  and IFN-  to interfere with DC polarization is in
accordance with our previous observations that the simul-
taneous exposure of immature DCs to both a maturation-
inducing agent and to recombinant IFN- , but not to ei-
ther of these factors alone, can induce type-1 polarized
DCs (27). In fact, TNF-  alone or another DC matura-
tion–inducing factor, bacterial LPS, both reduce the abil-
ity of DCs to produce IL-12 after subsequent stimulation
(Fig. 7 A), consistent with the previous reports (16, 27,
28). Similarly, the exposure of immature DCs to IFN-  in
the absence of any maturation-inducing stimulus does not
induce type-1 polarized DC phenotype, but paradoxically
reduces the ability of DCs to produce IL-12 (27). Al-
though TNF-  and IFN-  proved to be important medi-
ators of the CD8  T cell–dependent DC polarization,
even high doses of these factors consistently resulted in a
weaker polarization of DCs than CD8  T cell contact
(Fig. 7 B).
Discussion
Current models of the immune response recognize
MHC class I–restricted CD8  T cells as effector cells
against intracellular pathogens, reserving T helper function
for MHC class II–restricted CD4  T cells, that activate
DCs, instructing them to induce effector functions in
CD8  T cells (3–5). The present demonstration that hu-
man MHC class I–restricted CD8  T cells contribute to
DC activation, and induce Th1-promoting phenotype in
Figure 5. Different activation requirements of naive and
effector-type CD8  T cells to release TNF-  and induce
DC maturation. (A) Ability of effector, but not naive
CD8  T cells to activate bystander DCs upon the interac-
tion with nonprofessional APCs. Peripheral blood-isolated
CD8 CD45RA T cells and gp100-specific CD8  T cell
clone (2   105 cells/well) were stimulated in the upper
chamber of the transwell system with, respectively, the rele-
vant gp100 peptide or SEB, presented by HLA-A2 /
DR4  T2 cells or day 6 DCs (3   104 cells/well), as indi-
cated. The phenotype of the cells from the bottom cham-
ber was analyzed after 48 h. The additional negative control
groups (no antigen and no APCs) did not show any signs of
DC maturation, compared with the DCs cultured alone
(“control”) and were omitted from the figure, for the sake
of its clarity. (B) Production of TNF-  in the cocultures of
effector or naive CD8  T cells with nonprofessional APCs
or DCs. Peripheral blood–isolated CD8 CD45RA and
gp100-specific CD8  T cell clone (105 cells/well) were
stimulated for 48 h with, respectively, the relevant gp100
peptide or SEB, presented by HLA-A2 /DR4  T2 cells or
by day 6 DCs (2   104 cells/well), as indicated. No TNF- 
production was found in the supernatants from the addi-
tional negative control groups (no antigen and no APCs;
data not shown). (C) Neutralization of TNF-  in the direct
cocultures of SEB-presenting DCs with bulk isolated CD8  T cells (2   105 cells/well) using sTNF-RI (1ug/ml) effectively blocks the CD8  T cell–
mediated DC maturation. The data shown is from one experiment of three, that all gave similar results. TNF-RI showed a similar ability to block DC mat-
uration induced by in the gp100 specific CTL model (data not shown). (D). Neutralization of TNF-  with sTNF-RI (1  g/ml) effectively blocks the
CD8  T cell–mediated DC maturation (transwell experiments). DCs in the bottom chamber were exposed to the soluble products released in the cocul-
tures of SEB-presenting DCs (3   104 cells/well) with freshly-isolated bulk CD8  T cells (2   105 cells), present in the upper chamber.479 Mailliard et al.
DCs, indicates a novel role for human CD8  T cells as
“helper cells” during the induction of Th1-polarized in-
flammatory-type responses, and a role for DCs as effective
carriers of such “reverse” (CD8  to CD4 ) helper signals.
While a large body of data supports the role of DCs in
providing naive Th cells with the signals that drive immune
responses to Th1- or Th2-direction (29–31), it is unclear
how DCs distinguish between the different classes of
Figure 6. CD8  T cells induce type-1–
polarized DC phenotype. Day 6 DCs were
cocultured for 48 h with CD8  T cells either
in the absence or presence of relevant Ag or
Ag surrogate. Subsequently the cells were
washed, counted, and stimulated with J558-
CD40L, to analyze the production of IL-
12p70 in 24 h supernatants. (A) HLA-A2 
DCs cocultured directly with HLA-A2–
restricted gp100 (209–217)-specific (white
bars; top) or influenza specific (black bars;
bottom) CD8  T cells, in the presence of
the relevant class I–restricted peptides. Nei-
ther of the peptides showed any DC polar-
izing effect in the absence of specific T cells
(not shown). (B) DCs were activated with
peripheral blood-isolated bulk or naive
CD8  T cells in the presence of SEB. (C)
Bystander induction of DC maturation by
CD8  T cells. gp100-specific CD8  T
cells, or CD8  T cells freshly isolated from
peripheral blood (2   105 cells/well), were
stimulated in the top chamber of the transwell
system with, respectively, gp100 or SEB,
presented by (3   104 cells/well) HLA-A2/
DR4–expressing T2 cells (white bars, top)
or HLA-A2  DC (black bars, bottom). The
bottom chamber contained DCs only. DCs
from the bottom chamber were harvested
after 48 h, washed, and stimulated for 24 h
with J558-CD40L to analyze their ability to
produce IL-12. (D) Neutralization of either
TNF-  or IFN-  prevents type-1 DC po-
larization by gp100-specific CD8  T cells in
the direct coculture system (white bars) and in the transwell system (black bars). sTNF-R1 and sIFN- -R were used as neutralizing agents. The data
shown is from one experiment of two (direct cocultures) or three (transwell system), which yielded similar results. Similar results were also obtained in
the SEB model (not shown).
Figure 7. Reciprocal regula-
tion of the IL-12–producing ca-
pacity in maturing DCs by
CD8  T cells as opposed to bac-
terial LPS or an inflammatory
mediator, TNF- . (A) Day 6
DCs were either cultured for the
additional 48 h in the absence of
any stimuli (immature DCs), or
activated in the transwell system
(see Fig. 6) by the DC-stimulated
gp100-specific CD8  T cells
(2    105 cells/well). Alterna-
tively, DCs were preactivated by
the exposure to LPS or TNF- ,
as indicated. At day 8, DCs from
the bottom chamber were har-
vested, washed, and stimulated for 24 h with J558-CD40L, before harvesting of the supernatants and analyzing them for IL-12 concentration. The data
shown is from a representative experiment of five. (B) Comparison of the IL-12 production by CD8  T cell–polarized DCs and by DCs polarized by the
combination of exogenously added TNF-  and IFN- . Day 6 DCs were either exposed to gp100-specific CD8  T cells (2   105 cells) and gp100 pep-
tide (direct cocultures or transwell system) or to the standard concentrations of TNF-  and IFN-  (see Materials and Methods) or the high concentra-
tions of these factors (respectively, 100 ng/ml and 5,000 U/ml). At day 6, the cells were harvested, washed, and stimulated for 24 h with J558-CD40L.
The data shown is from one experiment of four, that showed similar results. The inset: J558-CD40L-induced IL-12p70 production by TNF-  and
IFN- –matured DCs and by DCs polarized by direct cocultures with gp100-specific CD8  T cells. The data is shown as a relative increase in IL-12p70
production compared with control immature DC (n   four different donors). The level of significance was determined by Student’s t test.480 Modulation of DC Functions by CD8  T Cells
pathogens that require Th1- versus Th2-type responses.
One previously proposed mechanism rests on the ability of
some intracellular pathogens to directly induce the produc-
tion of IL-12 or of another Th1-driving factor, IFN-  (9–
12, 32, 33). Another proposed scenario is a selective ability
of distinct types of pathogens to interact with different
Th1-inducing or Th2-inducing DC subpopulations (34),
e.g., via different pattern recognition receptors. The cur-
rent results suggest the existence of an additional “pathogen
activity-driven” mechanism, that is not contingent on the
ability of DCs themselves to interact with the pathogen
and/or to judge its molecular structure. In contrast to DCs
themselves, CD8  T cells that recognize class I–presented
peptides, mostly derived from the antigens present in cyto-
plasmic compartment of cells (35), have an intrinsic capac-
ity to determine the intracellular character of pathogens. In
addition to the antigens originating from their own cyto-
plasm, DCs are capable of class I presentation of pathogen-
related antigens acquired from dying cells (36). This ability
(cross-presentation), was previously postulated to allow
DCs to induce CD8  T cell responses against the patho-
gens that either do not infect DCs (37) or that developed
the means to suppress the functions of directly infected
APCs (38). The same ability, and the ability to receive po-
larizing signals in a bystander fashion, from CD8  T cells
detecting the infection of other cell types, may help DCs to
induce the desirable Th1 pattern of CD4  cell responses
against such pathogens, reducing their chances to evade the
immune system. The effectiveness of such a mechanism is
augmented by the ability of CD8  T cells to promote the
production of IL-12 by either being physically present dur-
ing DC–CD4  T cell interaction, or by inducing type-1
polarized effector DCs that will produce enhanced IL-12
levels upon a subsequent interaction with CD40L-express-
ing CD4  T cells. This allows the transmission of the DC-
mediated Th1-inducing signal without the need for the
Ag-specific CD8  T cells and CD4  T cells to interact
with DCs at the same time or at the same site.
The DC-modulating impact of CD8  T cells may ex-
plain their immunoregulatory function postulated by Ke-
meny (39). More recently, murine Ag-specific CD8  T
cells were shown to suppress the production of Th2 cyto-
kines and IgE in response to OVA (40). Furthermore, the
depletion of CD8  cells was recently shown to abrogate
the protective Th1-mediated responses after the DNA vac-
cination against Leishmania (41). CD8  T cells were also
demonstrated to shift the pattern of Th1/Th2-dependent
antibody isotypes during the response against Respiratory
Syncytial Virus (42).
CD8  T cell–dependent DC activation and polarization
may be also responsible for the different cytokine patterns
of the responses against Th1-inducing contact allergens as
opposed to the Th2-inducing atopic allergens. In contrast
to proteinaceous atopic allergens, presented mainly to
CD4  T cells in context of MHC class II, contact allergens
are effectively presented both by MHC class II and class I
molecules, and activate both CD4  and CD8  T cells (43).
This may lead to their perception by the immune system as
intracellular pathogens, resulting in the induction of IL-12
and mobilization of the inflammatory-type Th1-driven im-
munity, manifested as contact sensitization.
CD8  T cell–induced mature DCs are functionally dif-
ferent than DCs matured under the influence of bacterial
LPS or inflammatory cytokines, including IL-1   and
TNF- , which all show a maturation-related decrease in
the ability to produce IL-12 and to induce Th1 responses
(16, 28). We have reported that the exposure of DCs to re-
combinant IFN-  during the first hours of their TNF  /
IL-1 - or LPS-induced maturation reverses the matura-
tion-related decrease in IL-12 producing capacity (27).
The resulting type-1 polarized DCs produce up to 100-
fold more IL-12p70 than DCs matured by LPS or
TNF  /IL-1  alone. Although both IFN-  and TNF- 
proved to be involved in the currently described CD8  T
cell–induced DC polarization, the exposure of DCs to
these two factors was consistently giving weaker results
than the exposure of DCs to CD8  T cells (Fig. 7 B).
These observations may have several possible explanations:
first, they may suggest a participation of additional T cell–
derived factors. In line with this possibility, the neutraliza-
tion of IFN-  and TNF-  was more efficient in the trans-
well experiments than during direct cocultures (Fig. 6 D),
suggesting perhaps the additional role for membrane-
bound molecules. Alternatively, it may be the particular ki-
netic of the production of IFN-  and/or TNF-  during
CD8  T cell–DC interaction, particular concentrations of
these cytokines or their matched ratio at the contact area of
the interacting cells, that result in their optimal activity.
The above possibilities are being currently tested.
In sharp contrast to the observations made in the CD4 
T cell system (21–23), the ability to produce IFN-  and
the resulting ability to polarize DCs is present not only in
effector CD8  T cells and freshly isolated memory CD8 
T cells, but also in the cord blood– or peripheral blood–
isolated naive CD8  T cells, at the earliest stages of their
interaction with DCs. This suggests that CD8  T cells may
play a Th1-driving role already during the induction of pri-
mary immune responses. However, in contrast to effector
CD8  T cells that can release the DC-polarizing activity
after the stimulation by nonprofessional APCs, such as T2
cells, naive CD8  T cells need to be activated by an APC
providing a certain level of costimulation, such as the GM-
CSF– and IL-4–cultured (even if not fully mature) mono-
cyte-derived DCs (see Fig. 3 for the expression of costimu-
latory molecules on control CD83  DCs). This suggests
that, similar to naive CD4  T cells, naive CD8  T cells de-
pend on an initial pathogen-dependent DC activation in
order to further boost the activation status of DCs and in-
duce their type-1 polarization. Further studies are needed
to define what is the minimal level of activation permitting
DCs to effectively interact with naive CD8  T cells. Using
a TCR transgenic mouse model, Ruedl and colleagues
have shown that the injection of specific class I–restricted
peptide results in a massive activation of both the Ag-pre-
senting and bystander DCs (6). These observations indi-
cated the ability of naive CD8  T cells to activate resting481 Mailliard et al.
DCs in vivo, in a soluble factor-mediated mechanism. A
more recent study (7) showed that the transfer of 20   103
TCR-transgenic CD8  T cells allowed them to activate
DCs and function in a CD4  T cell–independent fashion
in recipient mice, while lower amounts of CD8  T cells
were unable to function autonomously. This requirement
for relatively high numbers of Ag-specific cells may explain
a strict requirement for additional DC-activating stimuli,
including the signals from CD4  T cells, in most of CD8 
T cell responses.
In our current experimental setup, we observed only a
marginal degree of DC killing in the experiments with
resting CD8 T cells, as well as in all cases of bystander DC
polarization, while even the direct cocultures of DCs with
gp100-specific CTL resulted with only up to 30% lower
DC recovery, compared with other modes of DC matura-
tion (data not shown). A recent paper showed that at least
some CTL clones may be more effective killers of imma-
ture bone marrow–derived mouse DCs and of the DC-like
D1 cells (44). It remains to be established whether any par-
ticular activation stages of CD8  T cells or particular sub-
sets of CD8  T cells, exert predominantly cytotoxic, rather
than DCs activating and polarizing roles. If this is the case,
helper signals from CD40L-expressing CD4  T cells, that
can protect DCs from Fas-mediated killing (45, 46), may
have additional importance.
The current results suggest a consensual, “socratic,”
rather than a hierarchical, “instructive,” model of the inter-
action between DCs, CD4 , and CD8  T cells, during the
induction of cell-mediated immune responses. In both
models, the activation of resting DCs by the pathogen (47)
or by the pathogen-induced tissue response (48) is required
for the migration of DCs to the lymph nodes and their
ability to activate naive T cells. The currently accepted
“hierarchical” model postulates that a subsequent step is
the CD40-CD40L–mediated interaction with Ag-specific
CD4  T cells, allowing DCs to acquire a “second-step”
level of activation and to effectively interact with naive
CD8  T cells (3–5). The current data and the results ob-
tained in the mouse (6, 7) suggest an alternative “socratic”
model, where CD4  and CD8  T cells act in a network-
like system, controlling each-others’ activity via bidirec-
tional DC-mediated signals. In this model, the combina-
tion of TNF- - and IFN- –dependent “CD8 help” and
CD40L-dependent “CD4 help” allows the pathogen-
mobilized DCs to acquire an optimal stimulatory function
and to produce IL-12, an important factor in the induction
of the effector functions and the long-term survival of
CTL, NK, and Th1 cells (8).
The DC-modulating function of CD8  T cells may
have implications for the design of vaccination strategies in
cancer, chronic infections, and allergy. KLH, a “heterolo-
gous” CD4  Th cell antigen, has been used to enhance the
efficacy of DC-based vaccination against melanoma (49).
The current results raise a possibility of using the heterolo-
gous help from CD8  T cells specific for common patho-
gens to optimize the character of DC-induced anti-tumor
responses, or to correct the pathogenic Th2-bias in atopy.
The feasibility of these approaches is currently being eval-
uated.
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